Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389049 · ClinicalTrials.gov registry record
Genetics of Primary Ciliary Dyskinesia
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 320
- Enrollment target
NCT02389049: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02389049 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 320 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02389049 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 320 participants
- Enrollment target
Study Summary
This study is designed to study DNA sequencings for mutations in a research genetic test panel of genes (which contains all 32 known and/or published genes associated with PCD). The study aims to show that about 70% of PCD patients have biallelic mutations in one of these genes. This project will enroll patients who have already had a clinical evaluation, and have clinical features consistent with PCD.
Primary Outcome
The primary objective is to perform research genetic (Ampliseq panel) testing in patients who are known or suspected to have PCD, based on previous research or future clinical and lab characterization by certified clinical research sites. We will define the prevalence of biallelic PCD-causing mutations in patients who fulfill criteria of very high likelihood of PCD, as well as prevalence in other patients with some features of PCD. We anticipate successful completion of this objective will provi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2015-02 |
| Est. Completion | 2018-07 |
What the finished NCT02389049 record still lists
NCT02389049 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02389049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02389049 about?
NCT02389049 is a clinical study titled "Genetics of Primary Ciliary Dyskinesia". This study is designed to study DNA sequencings for mutations in a research genetic test panel of genes (which contains all 32 known and/or published genes associated with PCD). The study aims to show that about 70% of PCD patients have biallelic mutations in one of these genes. This project will en...
What is the current status of trial NCT02389049?
This trial is currently completed. The enrollment target is 320 participants. The study started on 2015-02. Estimated completion is 2018-07.
Who is sponsoring clinical trial NCT02389049?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia